Ignite Creation Date:
2025-12-24 @ 7:50 PM
Ignite Modification Date:
2026-01-02 @ 4:42 PM
Study NCT ID:
NCT03264404
Status:
COMPLETED
Last Update Posted:
2025-06-17
First Post:
2017-08-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Azacitidine and Pembrolizumab in Pancreatic Cancer
Sponsor:
Susan E. Bates
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-03
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-22
First Submit QC Date:
None
Study First Post Date:
2017-08-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-06-08
Results First Submit QC Date:
None
Results First Post Date:
2023-07-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-06
Last Update Post Date:
2025-06-17
Last Update Post Date Type:
ACTUAL